LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Va.), 2022-06, Vol.24 (Supplement_1), p.i191-i192
Main Authors: Robison, Nathan, Pauly, Jasmine, Malvar, Jemily, Gardner, Sharon, Allen, Jeffrey, Margol, Ashley, MacDonald, Tobey, Bendel, Anne, Kilburn, Lindsay, Cluster, Andrew, Bowers, Daniel, Dorris, Kathleen, Ullrich, Nicole, De Mola, Rebecca Loret, Alva, Elizabeth, Leary, Sarah, Baxter, Patricia, Khatib, Ziad, Cohen, Kenneth, Davidson, Tom Belle, Plant, Ashley, Bandopadhayay, Pratiti, Stopka, Sylwia, Agar, Nathalie, Wright, Karen, Nelson, Marvin, Chi, Yueh-Yun, Kieran, Mark
Format: Article
Language:English
Subjects:
Late Breaking Abstracts
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1916-3a25a9255ecab324c9cf3617cf75a0c7cf8f5ab3ad0bb000c16de84e582e4eb03
cites
container_end_page i192
container_issue Supplement_1
container_start_page i191
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 24
creator Robison, Nathan
Pauly, Jasmine
Malvar, Jemily
Gardner, Sharon
Allen, Jeffrey
Margol, Ashley
MacDonald, Tobey
Bendel, Anne
Kilburn, Lindsay
Cluster, Andrew
Bowers, Daniel
Dorris, Kathleen
Ullrich, Nicole
De Mola, Rebecca Loret
Alva, Elizabeth
Leary, Sarah
Baxter, Patricia
Khatib, Ziad
Cohen, Kenneth
Davidson, Tom Belle
Plant, Ashley
Bandopadhayay, Pratiti
Stopka, Sylwia
Agar, Nathalie
Wright, Karen
Nelson, Marvin
Chi, Yueh-Yun
Kieran, Mark
description
doi_str_mv 10.1093/neuonc/noac079.716
format article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9189933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_9189933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1916-3a25a9255ecab324c9cf3617cf75a0c7cf8f5ab3ad0bb000c16de84e582e4eb03</originalsourceid><addsrcrecordid>eNpVkd1q20AQhUVpoWmaF-jVXKYXcvbHq59cFGTjpsZuC4l6vYxWK3mDtGt2Vw55pz5klToUejNn4MwcOHxJ8omSBSUlv7F6clbdWIeK5OUip9mb5IIKxlNRZNnbvztLC0Hz98mHEB4JYVRk9CL5va9Xu5QsF7Cv6g2s7jfVbvvjDqrVQ31fretb-L7Z0YzBdWOsGXWcZ_MZjAV1MEPrtYUnEw9w9K73OgRz0uA8eK0mP5sRBveU9h5bDf1g3Ii3gDBOQzSpsSGaOEXjLA5wPGDQsN0C2hYi-l5HOOFgWnw5gBCn9vlj8q7DIeirV71Mfn3d1Otv6f7n3XZd7VNFS5qlHJnAkgmhFTacLVWpOp7RXHW5QKJmLToxO9iSpiGEKJq1ulhqUTC91A3hl8mXc-5xakbdqrmHx0EevRnRP0uHRv7vWHOQvTvJkhZlyfkcwM4ByrsQvO7-_VIiX4DJMzD5CkzOwPgfDc2O4A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study</title><source>Open Access: PubMed Central</source><source>Oxford Journals Online</source><creator>Robison, Nathan ; Pauly, Jasmine ; Malvar, Jemily ; Gardner, Sharon ; Allen, Jeffrey ; Margol, Ashley ; MacDonald, Tobey ; Bendel, Anne ; Kilburn, Lindsay ; Cluster, Andrew ; Bowers, Daniel ; Dorris, Kathleen ; Ullrich, Nicole ; De Mola, Rebecca Loret ; Alva, Elizabeth ; Leary, Sarah ; Baxter, Patricia ; Khatib, Ziad ; Cohen, Kenneth ; Davidson, Tom Belle ; Plant, Ashley ; Bandopadhayay, Pratiti ; Stopka, Sylwia ; Agar, Nathalie ; Wright, Karen ; Nelson, Marvin ; Chi, Yueh-Yun ; Kieran, Mark</creator><creatorcontrib>Robison, Nathan ; Pauly, Jasmine ; Malvar, Jemily ; Gardner, Sharon ; Allen, Jeffrey ; Margol, Ashley ; MacDonald, Tobey ; Bendel, Anne ; Kilburn, Lindsay ; Cluster, Andrew ; Bowers, Daniel ; Dorris, Kathleen ; Ullrich, Nicole ; De Mola, Rebecca Loret ; Alva, Elizabeth ; Leary, Sarah ; Baxter, Patricia ; Khatib, Ziad ; Cohen, Kenneth ; Davidson, Tom Belle ; Plant, Ashley ; Bandopadhayay, Pratiti ; Stopka, Sylwia ; Agar, Nathalie ; Wright, Karen ; Nelson, Marvin ; Chi, Yueh-Yun ; Kieran, Mark</creatorcontrib><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noac079.716</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Late Breaking Abstracts</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i191-i192</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1916-3a25a9255ecab324c9cf3617cf75a0c7cf8f5ab3ad0bb000c16de84e582e4eb03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189933/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189933/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Robison, Nathan</creatorcontrib><creatorcontrib>Pauly, Jasmine</creatorcontrib><creatorcontrib>Malvar, Jemily</creatorcontrib><creatorcontrib>Gardner, Sharon</creatorcontrib><creatorcontrib>Allen, Jeffrey</creatorcontrib><creatorcontrib>Margol, Ashley</creatorcontrib><creatorcontrib>MacDonald, Tobey</creatorcontrib><creatorcontrib>Bendel, Anne</creatorcontrib><creatorcontrib>Kilburn, Lindsay</creatorcontrib><creatorcontrib>Cluster, Andrew</creatorcontrib><creatorcontrib>Bowers, Daniel</creatorcontrib><creatorcontrib>Dorris, Kathleen</creatorcontrib><creatorcontrib>Ullrich, Nicole</creatorcontrib><creatorcontrib>De Mola, Rebecca Loret</creatorcontrib><creatorcontrib>Alva, Elizabeth</creatorcontrib><creatorcontrib>Leary, Sarah</creatorcontrib><creatorcontrib>Baxter, Patricia</creatorcontrib><creatorcontrib>Khatib, Ziad</creatorcontrib><creatorcontrib>Cohen, Kenneth</creatorcontrib><creatorcontrib>Davidson, Tom Belle</creatorcontrib><creatorcontrib>Plant, Ashley</creatorcontrib><creatorcontrib>Bandopadhayay, Pratiti</creatorcontrib><creatorcontrib>Stopka, Sylwia</creatorcontrib><creatorcontrib>Agar, Nathalie</creatorcontrib><creatorcontrib>Wright, Karen</creatorcontrib><creatorcontrib>Nelson, Marvin</creatorcontrib><creatorcontrib>Chi, Yueh-Yun</creatorcontrib><creatorcontrib>Kieran, Mark</creatorcontrib><title>LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study</title><title>Neuro-oncology (Charlottesville, Va.)</title><subject>Late Breaking Abstracts</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkd1q20AQhUVpoWmaF-jVXKYXcvbHq59cFGTjpsZuC4l6vYxWK3mDtGt2Vw55pz5klToUejNn4MwcOHxJ8omSBSUlv7F6clbdWIeK5OUip9mb5IIKxlNRZNnbvztLC0Hz98mHEB4JYVRk9CL5va9Xu5QsF7Cv6g2s7jfVbvvjDqrVQ31fretb-L7Z0YzBdWOsGXWcZ_MZjAV1MEPrtYUnEw9w9K73OgRz0uA8eK0mP5sRBveU9h5bDf1g3Ii3gDBOQzSpsSGaOEXjLA5wPGDQsN0C2hYi-l5HOOFgWnw5gBCn9vlj8q7DIeirV71Mfn3d1Otv6f7n3XZd7VNFS5qlHJnAkgmhFTacLVWpOp7RXHW5QKJmLToxO9iSpiGEKJq1ulhqUTC91A3hl8mXc-5xakbdqrmHx0EevRnRP0uHRv7vWHOQvTvJkhZlyfkcwM4ByrsQvO7-_VIiX4DJMzD5CkzOwPgfDc2O4A</recordid><startdate>20220613</startdate><enddate>20220613</enddate><creator>Robison, Nathan</creator><creator>Pauly, Jasmine</creator><creator>Malvar, Jemily</creator><creator>Gardner, Sharon</creator><creator>Allen, Jeffrey</creator><creator>Margol, Ashley</creator><creator>MacDonald, Tobey</creator><creator>Bendel, Anne</creator><creator>Kilburn, Lindsay</creator><creator>Cluster, Andrew</creator><creator>Bowers, Daniel</creator><creator>Dorris, Kathleen</creator><creator>Ullrich, Nicole</creator><creator>De Mola, Rebecca Loret</creator><creator>Alva, Elizabeth</creator><creator>Leary, Sarah</creator><creator>Baxter, Patricia</creator><creator>Khatib, Ziad</creator><creator>Cohen, Kenneth</creator><creator>Davidson, Tom Belle</creator><creator>Plant, Ashley</creator><creator>Bandopadhayay, Pratiti</creator><creator>Stopka, Sylwia</creator><creator>Agar, Nathalie</creator><creator>Wright, Karen</creator><creator>Nelson, Marvin</creator><creator>Chi, Yueh-Yun</creator><creator>Kieran, Mark</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20220613</creationdate><title>LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study</title><author>Robison, Nathan ; Pauly, Jasmine ; Malvar, Jemily ; Gardner, Sharon ; Allen, Jeffrey ; Margol, Ashley ; MacDonald, Tobey ; Bendel, Anne ; Kilburn, Lindsay ; Cluster, Andrew ; Bowers, Daniel ; Dorris, Kathleen ; Ullrich, Nicole ; De Mola, Rebecca Loret ; Alva, Elizabeth ; Leary, Sarah ; Baxter, Patricia ; Khatib, Ziad ; Cohen, Kenneth ; Davidson, Tom Belle ; Plant, Ashley ; Bandopadhayay, Pratiti ; Stopka, Sylwia ; Agar, Nathalie ; Wright, Karen ; Nelson, Marvin ; Chi, Yueh-Yun ; Kieran, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1916-3a25a9255ecab324c9cf3617cf75a0c7cf8f5ab3ad0bb000c16de84e582e4eb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Late Breaking Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robison, Nathan</creatorcontrib><creatorcontrib>Pauly, Jasmine</creatorcontrib><creatorcontrib>Malvar, Jemily</creatorcontrib><creatorcontrib>Gardner, Sharon</creatorcontrib><creatorcontrib>Allen, Jeffrey</creatorcontrib><creatorcontrib>Margol, Ashley</creatorcontrib><creatorcontrib>MacDonald, Tobey</creatorcontrib><creatorcontrib>Bendel, Anne</creatorcontrib><creatorcontrib>Kilburn, Lindsay</creatorcontrib><creatorcontrib>Cluster, Andrew</creatorcontrib><creatorcontrib>Bowers, Daniel</creatorcontrib><creatorcontrib>Dorris, Kathleen</creatorcontrib><creatorcontrib>Ullrich, Nicole</creatorcontrib><creatorcontrib>De Mola, Rebecca Loret</creatorcontrib><creatorcontrib>Alva, Elizabeth</creatorcontrib><creatorcontrib>Leary, Sarah</creatorcontrib><creatorcontrib>Baxter, Patricia</creatorcontrib><creatorcontrib>Khatib, Ziad</creatorcontrib><creatorcontrib>Cohen, Kenneth</creatorcontrib><creatorcontrib>Davidson, Tom Belle</creatorcontrib><creatorcontrib>Plant, Ashley</creatorcontrib><creatorcontrib>Bandopadhayay, Pratiti</creatorcontrib><creatorcontrib>Stopka, Sylwia</creatorcontrib><creatorcontrib>Agar, Nathalie</creatorcontrib><creatorcontrib>Wright, Karen</creatorcontrib><creatorcontrib>Nelson, Marvin</creatorcontrib><creatorcontrib>Chi, Yueh-Yun</creatorcontrib><creatorcontrib>Kieran, Mark</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robison, Nathan</au><au>Pauly, Jasmine</au><au>Malvar, Jemily</au><au>Gardner, Sharon</au><au>Allen, Jeffrey</au><au>Margol, Ashley</au><au>MacDonald, Tobey</au><au>Bendel, Anne</au><au>Kilburn, Lindsay</au><au>Cluster, Andrew</au><au>Bowers, Daniel</au><au>Dorris, Kathleen</au><au>Ullrich, Nicole</au><au>De Mola, Rebecca Loret</au><au>Alva, Elizabeth</au><au>Leary, Sarah</au><au>Baxter, Patricia</au><au>Khatib, Ziad</au><au>Cohen, Kenneth</au><au>Davidson, Tom Belle</au><au>Plant, Ashley</au><au>Bandopadhayay, Pratiti</au><au>Stopka, Sylwia</au><au>Agar, Nathalie</au><au>Wright, Karen</au><au>Nelson, Marvin</au><au>Chi, Yueh-Yun</au><au>Kieran, Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2022-06-13</date><risdate>2022</risdate><volume>24</volume><issue>Supplement_1</issue><spage>i191</spage><epage>i192</epage><pages>i191-i192</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/neuonc/noac079.716</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i191-i192
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9189933
source Open Access: PubMed Central; Oxford Journals Online
subjects Late Breaking Abstracts
title LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LTBK-04.%20LATE%20BREAKING%20ABSTRACT:%20MEK162%20(binimetinib)%20in%20children%20with%20progressive%20or%20recurrent%20low-grade%20glioma:%20a%20multi-institutional%20phase%20II%20and%20target%20validation%20study&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Robison,%20Nathan&rft.date=2022-06-13&rft.volume=24&rft.issue=Supplement_1&rft.spage=i191&rft.epage=i192&rft.pages=i191-i192&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noac079.716&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_9189933%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1916-3a25a9255ecab324c9cf3617cf75a0c7cf8f5ab3ad0bb000c16de84e582e4eb03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true